cCAM Biotherapeutics
cCAM Biotherapeutics is focused on the discovery and development of novel immunotherapies to treat cancer.
Business Model:
Revenue: $0
Employees: 2-10
Rankings
Industries / Tags:
Detailed cCAM Biotherapeutics Information
cCAM Biotherapeutics was acquired by
Merck.
The acquisition happend on 2015-07-28.
Details of the transaction were not public
Acquirer
Geographic Data
Address: Misgav Industrial Park, POB 79
City: Misgav
State: north district
Zip: 2017400
Country: IL
Financial Info
Stage:
series a
Raised Last:
$0
Raised Total:$4M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
cCAM Biotherapeutics is focused on the discovery and development of novel immunotherapies to treat cancer.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2012 | Series A | 3 | - |
Arkin Holdings OrbiMed Pontifax Arkin Holdings OrbiMed Pontifax |
9/2012 | Series A | $4.3M |
Arkin Holdings OrbiMed Israel Partners Pontifax Ltd. F. Hoffmann La Roche Ltd . |
9/2012 | Series A | 3 | - |
Arkin Holdings OrbiMed Pontifax Arkin Holdings OrbiMed Pontifax |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
